Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-month open-label safety study of pregabalin in adolescents with fibromyalgia
2010-020300-29Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in fibromyalgia (FM), sponsored by Pfizer. Primary endpoints: Safety outcomes and Efficacy endpoint. Started Jun 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2010-020300-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020300-29.